What BMI do I need to qualify for GLP-1 medication?

Most GLP-1 providers require a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea. Some telehealth providers assess patients individually even at lower BMIs.

Does insurance cover GLP-1 weight loss medication?

Many major insurance plans cover GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) when prescribed for weight loss or diabetes. Coverage varies by state, plan type, and diagnosis. Use our free eligibility checker to see your options based on your state and BMI.

Can I get GLP-1 medication online without an in-person doctor visit?

Yes. Several licensed telehealth providers can prescribe GLP-1 medications online after a virtual consultation. The medication is then shipped directly to your home. No in-person visit is required.

How long does the eligibility screening take?

The free US Metabolic Eligibility Screening takes approximately 60 seconds. You answer 4 short questions about your location, sex, height/weight, and health goal, and receive instant results.

What is the difference between Ozempic, Wegovy, Mounjaro, and Zepbound?

Ozempic and Wegovy both contain semaglutide — Ozempic is FDA-approved for type 2 diabetes while Wegovy is approved for weight loss. Mounjaro and Zepbound both contain tirzepatide — Mounjaro is for diabetes and Zepbound for weight loss. All four are GLP-1 receptor agonists and can be prescribed through telehealth.

US Metabolic Eligibility Triage

Find Your Metabolic & Longevity Pathway

Free clinical-grade screening: find your metabolic & longevity pathway in 60 seconds. GLP-1 eligibility, NAD+ protocols, nutrition plans. No sign-up.

Answer four short questions. We'll match you to evidence-based options—from GLP-1 eligibility to NAD+ protocols and nutrition plans—based on your profile and state.

50,000+ screenings | 4.9/5 from users | Free · 60 seconds · No commitment

Please enable JavaScript to use the interactive screening tool.